BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kabatas S, Civelek E, Savrunlu EC, Karaaslan U, Yıldız Ö, Karaöz E. Advances in the treatment of autism spectrum disorder: Wharton jelly mesenchymal stem cell transplantation. World J Methodol 2025; 15(1): 95857 [PMID: 40115399 DOI: 10.5662/wjm.v15.i1.95857]
URL: https://www.wjgnet.com/2222-0682/full/v15/i1/95857.htm
Number Citing Articles
1
Tomasz Górnicki, Małgorzata Józkowiak, Krzysztof Data, Dominika Domagała, Julia Niebora, Ewa Okowińska, Anna Kłopot, Magdalena Kulus, Artur Bryja, Sławomir Woźniak, Adam Kamiński, Piotr Chmielewski, Aleksandra Górska, Aleksandra Partyńska, Teresa Wysocka, Marek Spaczyński, Hanna Piotrowska-Kempisty, Piotr Dzięgiel, Paul Mozdziak, Bogusław Czerny, Bartosz Kempisty. Wharton’s jelly mesenchymal stem cells (WJ-MSCs), a “Holy Grail” in tissue bioengineering and reconstructive medicineBiomedicine & Pharmacotherapy 2025; 192: 118570 doi: 10.1016/j.biopha.2025.118570
2
Caixia Wu, Xianjie Li, Xiaoya Yang, Han Wang, Guanzhen Lin, Zhaoming Liu. ‌Dual-target hUCMSCs/EVs therapy for autism spectrum disorder: remodeling gut microbiota and modulating neuroimmune crosstalk in a valproic acid-induced C57BL/6 mice modelStem Cell Research & Therapy 2025;  doi: 10.1186/s13287-025-04829-x
3
FAHAD AHMED. Integrating Artificial Intelligence and Big Data Analytics in Personalized Autism Treatment through Stem Cell TherapySSRN Electronic Journal 2025;  doi: 10.2139/ssrn.5426255